Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

European Multicentre Tics in Children Studies (EMTICS): protocol for two cohort studies to assess risk factors for tic onset and exacerbation in children and adolescents.

Schrag A, Martino D, Apter A, Ball J, Bartolini E, Benaroya-Milshtein N, Buttiglione M, Cardona F, Creti R, Efstratiou A, Gariup M, Georgitsi M, Hedderly T, Heyman I, Margarit I, Mir P, Moll N, Morer A, Müller N, Müller-Vahl K, Münchau A, Orefici G, Plessen KJ, Porcelli C, Paschou P, Rizzo R, Roessner V, Schwarz MJ, Steinberg T, Tagwerker Gloor F, Tarnok Z, Walitza S, Dietrich A, Hoekstra PJ; EMTICS Collaborative Group.

Eur Child Adolesc Psychiatry. 2019 Jan;28(1):91-109. doi: 10.1007/s00787-018-1190-4. Epub 2018 Jul 7.

2.

Neonatal protection and preterm birth reduction following maternal group B streptococcus vaccination in a mouse model.

Bernardini R, Aufieri R, Detcheva A, Recchia S, Cicconi R, Amicosante M, Montesano C, Rossi P, Tchidjou HK, Petrunov B, Orefici G, Mattei M.

J Matern Fetal Neonatal Med. 2017 Dec;30(23):2844-2850. doi: 10.1080/14767058.2016.1265932. Epub 2016 Dec 14.

PMID:
27973991
3.

Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS).

Orefici G, Cardona F, Cox CJ, Cunningham MW.

In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes : Basic Biology to Clinical Manifestations [Internet]. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2016-.
2016 Feb 10.

4.

Mice repeatedly exposed to Group-A β-Haemolytic Streptococcus show perseverative behaviors, impaired sensorimotor gating, and immune activation in rostral diencephalon.

Macrì S, Ceci C, Onori MP, Invernizzi RW, Bartolini E, Altabella L, Canese R, Imperi M, Orefici G, Creti R, Margarit I, Magliozzi R, Laviola G.

Sci Rep. 2015 Aug 25;5:13257. doi: 10.1038/srep13257.

5.

Significant Differences Characterise the Correlation Coefficients between Biocide and Antibiotic Susceptibility Profiles in Staphylococcus aureus.

Oggioni MR, Coelho JR, Furi L, Knight DR, Viti C, Orefici G, Martinez JL, Freitas AT, Coque TM, Morrissey I; BIOHYPO consortium.

Curr Pharm Des. 2015;21(16):2054-7.

6.

Evaluation of reduced susceptibility to quaternary ammonium compounds and bisbiguanides in clinical isolates and laboratory-generated mutants of Staphylococcus aureus.

Furi L, Ciusa ML, Knight D, Di Lorenzo V, Tocci N, Cirasola D, Aragones L, Coelho JR, Freitas AT, Marchi E, Moce L, Visa P, Northwood JB, Viti C, Borghi E, Orefici G; BIOHYPO Consortium, Morrissey I, Oggioni MR.

Antimicrob Agents Chemother. 2013 Aug;57(8):3488-97. doi: 10.1128/AAC.00498-13. Epub 2013 May 13.

7.

Lack of evidence for reduced fitness of clinical Staphylococcus aureus isolates with reduced susceptibility to triclosan.

Oggioni MR, Ciusa ML, Furi L, Baldassarri L, Orefici G, Cirasola D, Martinez JL, Morrissey I, Borghi E.

Antimicrob Agents Chemother. 2012 Nov;56(11):6068-9; author reply 6072. doi: 10.1128/AAC.01055-12. No abstract available.

8.

A novel resistance mechanism to triclosan that suggests horizontal gene transfer and demonstrates a potential selective pressure for reduced biocide susceptibility in clinical strains of Staphylococcus aureus.

Ciusa ML, Furi L, Knight D, Decorosi F, Fondi M, Raggi C, Coelho JR, Aragones L, Moce L, Visa P, Freitas AT, Baldassarri L, Fani R, Viti C, Orefici G, Martinez JL, Morrissey I, Oggioni MR; BIOHYPO Consortium.

Int J Antimicrob Agents. 2012 Sep;40(3):210-20. Epub 2012 Jul 11.

9.

Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project.

Rodriguez-Granger J, Alvargonzalez JC, Berardi A, Berner R, Kunze M, Hufnagel M, Melin P, Decheva A, Orefici G, Poyart C, Telford J, Efstratiou A, Killian M, Krizova P, Baldassarri L, Spellerberg B, Puertas A, Rosa-Fraile M.

Eur J Clin Microbiol Infect Dis. 2012 Sep;31(9):2097-104. Review.

PMID:
22314410
10.

Treatment of tuberculosis in a region with high drug resistance: outcomes, drug resistance amplification and re-infection.

Bonnet M, Pardini M, Meacci F, Orrù G, Yesilkaya H, Jarosz T, Andrew PW, Barer M, Checchi F, Rinder H, Orefici G, Rüsch-Gerdes S, Fattorini L, Oggioni MR, Melzer J, Niemann S, Varaine F.

PLoS One. 2011;6(8):e23081. doi: 10.1371/journal.pone.0023081. Epub 2011 Aug 23.

11.

Invasive neonatal GBS infections from an area-based surveillance study in Italy.

Imperi M, Gherardi G, Berardi A, Baldassarri L, Pataracchia M, Dicuonzo G, Orefici G, Creti R.

Clin Microbiol Infect. 2011 Dec;17(12):1834-9. doi: 10.1111/j.1469-0691.2011.03479.x. Epub 2011 Jul 1.

12.

The relationship between group A streptococcal infections and Tourette syndrome: a study on a large service-based cohort.

Martino D, Chiarotti F, Buttiglione M, Cardona F, Creti R, Nardocci N, Orefici G, Veneselli E, Rizzo R; Italian Tourette Syndrome Study Group.

Dev Med Child Neurol. 2011 Oct;53(10):951-7. doi: 10.1111/j.1469-8749.2011.04018.x. Epub 2011 Jun 17.

13.

International external quality assurance for laboratory identification and typing of Streptococcus agalactiae (Group B streptococci).

Afshar B, Broughton K, Creti R, Decheva A, Hufnagel M, Kriz P, Lambertsen L, Lovgren M, Melin P, Orefici G, Poyart C, Radtke A, Rodriguez-Granger J, Sørensen UB, Telford J, Valinsky L, Zachariadou L; Members of the DEVANI Study Group, Efstratiou A.

J Clin Microbiol. 2011 Apr;49(4):1475-82. doi: 10.1128/JCM.02365-10. Epub 2011 Feb 16.

14.

A multiplex PCR assay for the direct identification of the capsular type (Ia to IX) of Streptococcus agalactiae.

Imperi M, Pataracchia M, Alfarone G, Baldassarri L, Orefici G, Creti R.

J Microbiol Methods. 2010 Feb;80(2):212-4. doi: 10.1016/j.mimet.2009.11.010. Epub 2009 Dec 1.

PMID:
19958797
15.

Protein array profiling of tic patient sera reveals a broad range and enhanced immune response against Group A Streptococcus antigens.

Bombaci M, Grifantini R, Mora M, Reguzzi V, Petracca R, Meoni E, Balloni S, Zingaretti C, Falugi F, Manetti AG, Margarit I, Musser JM, Cardona F, Orefici G, Grandi G, Bensi G.

PLoS One. 2009 Jul 22;4(7):e6332. doi: 10.1371/journal.pone.0006332.

16.

Characteristics of drug-resistant tuberculosis in Abkhazia (Georgia), a high-prevalence area in Eastern Europe.

Pardini M, Niemann S, Varaine F, Iona E, Meacci F, Orrù G, Yesilkaya H, Jarosz T, Andrew P, Barer M, Checchi F, Rinder H, Orefici G, Rüsch-Gerdes S, Fattorini L, Oggioni MR, Bonnet M.

Tuberculosis (Edinb). 2009 Jul;89(4):317-24. doi: 10.1016/j.tube.2009.04.002. Epub 2009 Jun 17.

PMID:
19539531
17.

Sequence variation in group A Streptococcus pili and association of pilus backbone types with lancefield T serotypes.

Falugi F, Zingaretti C, Pinto V, Mariani M, Amodeo L, Manetti AG, Capo S, Musser JM, Orefici G, Margarit I, Telford JL, Grandi G, Mora M.

J Infect Dis. 2008 Dec 15;198(12):1834-41. doi: 10.1086/593176.

PMID:
18928376
18.

External quality control of Mycobacterium tuberculosis drug susceptibility testing: results of two rounds in endemic countries.

Fattorini L, Iona E, Cirillo D, Migliori GB, Orefici G, Aziz M, Wright A, Tafaj S, Baig B, Mulliqi G, Maungate S, Cuna Z, Al-Busaidy S, Al-Suwaidi Z, Ceyhan I.

Int J Tuberc Lung Dis. 2008 Feb;12(2):214-7.

PMID:
18230256
19.

Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy.

Gherardi G, Imperi M, Baldassarri L, Pataracchia M, Alfarone G, Recchia S, Orefici G, Dicuonzo G, Creti R.

J Clin Microbiol. 2007 Sep;45(9):2909-16. Epub 2007 Jul 18.

20.

Squamous cell carcinoma secondary to buruli ulcer.

Minutilli E, Orefici G, Pardini M, Giannoni F, Muscardin LM, Massi G, Sanguinetti M, Fadda G, Di Miceli D, Doglietto GB.

Dermatol Surg. 2007 Jul;33(7):872-5. No abstract available.

PMID:
17598858
21.

emm Types, virulence factors, and antibiotic resistance of invasive Streptococcus pyogenes isolates from Italy: What has changed in 11 years?

Creti R, Imperi M, Baldassarri L, Pataracchia M, Recchia S, Alfarone G, Orefici G.

J Clin Microbiol. 2007 Jul;45(7):2249-56. Epub 2007 May 9.

22.

A post-streptococcal pathogenesis in children with tic disorders is suggested by a color Doppler echocardiographic study.

Cardona F, Ventriglia F, Cipolla O, Romano A, Creti R, Orefici G.

Eur J Paediatr Neurol. 2007 Sep;11(5):270-6. Epub 2007 Apr 2.

PMID:
17403609
23.

Pyrazinamide resistance in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Abkhazia.

Pardini M, Varaine F, Hewison C, Iona E, Pataracchia M, Orefici G, Fattorini L.

J Chemother. 2007 Feb;19(1):106-7. No abstract available.

PMID:
17309862
24.

Detection of genes encoding internalization-associated proteins in Streptococcus pyogenes isolates from patients with invasive diseases and asymptomatic carriers.

Baldassarri L, Creti R, Imperi M, Recchia S, Pataracchia M, Orefici G.

J Clin Microbiol. 2007 Apr;45(4):1284-7. Epub 2007 Feb 7.

25.

Lateral transfer of alpha-like protein gene cassettes among streptococci: identification of a new family member in Streptococcus dysgalactiae subsp. equisimilis.

Creti R, Imperi M, Baldassarri L, Pataracchia M, Alfarone G, Orefici G.

Lett Appl Microbiol. 2007 Feb;44(2):224-7. No abstract available.

26.

The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.

Palma C, Iona E, Giannoni F, Pardini M, Brunori L, Orefici G, Fattorini L, Cassone A.

Cell Microbiol. 2007 Jun;9(6):1455-65. Epub 2007 Jan 22.

PMID:
17250590
27.

Metronidazole plus rifampin sterilizes long-term dormant Mycobacterium tuberculosis.

Iona E, Giannoni F, Pardini M, Brunori L, Orefici G, Fattorini L.

Antimicrob Agents Chemother. 2007 Apr;51(4):1537-40. Epub 2007 Jan 22.

28.

Usefulness of the BACTEC MGIT 960 system for isolation of mycobacterium tuberculosis from sputa subjected to long-term storage.

Pardini M, Varaine F, Bonnet M, Orefici G, Oggioni MR; LONG-DRUG Study Group, Fattorini L.

J Clin Microbiol. 2007 Feb;45(2):575-6. Epub 2006 Nov 22.

29.

Therapeutic failures of antibiotics used to treat macrolide-susceptible Streptococcus pyogenes infections may be due to biofilm formation.

Baldassarri L, Creti R, Recchia S, Imperi M, Facinelli B, Giovanetti E, Pataracchia M, Alfarone G, Orefici G.

J Clin Microbiol. 2006 Aug;44(8):2721-7.

30.

Exacerbation of group B streptococcal sepsis and arthritis in diabetic mice.

Puliti M, Bistoni F, Orefici G, Tissi L.

Microbes Infect. 2006 Aug;8(9-10):2376-83. Epub 2006 Jun 30.

PMID:
16844399
31.

Virulence factors in enterococcal infections of orthopedic devices.

Baldassarri L, Creti R, Recchia S, Pataracchia M, Alfarone G, Orefici G, Campoccia D, Montanaro L, Arciola CR.

Int J Artif Organs. 2006 Apr;29(4):402-6.

PMID:
16705609
32.

Staphylococcus aureus epidemic in a neonatal nursery: a strategy of infection control.

Bertini G, Nicoletti P, Scopetti F, Manoocher P, Dani C, Orefici G.

Eur J Pediatr. 2006 Aug;165(8):530-5. Epub 2006 Apr 7.

PMID:
16602005
33.

Pathogenesis of implant infections by enterococci.

Baldassarri L, Creti R, Montanaro L, Orefici G, Arciola CR.

Int J Artif Organs. 2005 Nov;28(11):1101-9. Review.

PMID:
16353116
34.

Association of group A streptococcal emm types with virulence traits and macrolide-resistance genes is independent of the source of isolation.

Creti R, Gherardi G, Imperi M, von Hunolstein C, Baldassarri L, Pataracchia M, Alfarone G, Cardona F, Dicuonzo G, Orefici G.

J Med Microbiol. 2005 Oct;54(Pt 10):913-7.

PMID:
16157543
35.

Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis.

Giannoni F, Iona E, Sementilli F, Brunori L, Pardini M, Migliori GB, Orefici G, Fattorini L.

Antimicrob Agents Chemother. 2005 Jul;49(7):2928-33.

36.

Clonality among Enterococcus faecium clinical isolates.

Baldassarri L, Bertuccini L, Creti R, Orefici G, Dicuonzo G, Gherardi G, Venditti M, Di Rosa R.

Microb Drug Resist. 2005 Summer;11(2):141-5.

PMID:
15910228
37.

SWIFT (sequence-wide investigation with Fourier transform): a software tool for identifying proteins of a given class from the unannotated genome sequence.

D'Avenio G, Grigioni M, Orefici G, Creti R.

Bioinformatics. 2005 Jul 1;21(13):2943-9. Epub 2005 Apr 28.

PMID:
15860563
38.

A Pyrosequencing assay for rapid recognition of SNPs in Mycobacterium tuberculosis embB306 region.

Isola D, Pardini M, Varaine F, Niemann S, Rüsch-Gerdes S, Fattorini L, Orefici G, Meacci F, Trappetti C, Rinaldo Oggioni M, Orrù G; LONG-DRUG study group.

J Microbiol Methods. 2005 Jul;62(1):113-20.

PMID:
15823399
39.

Mycobacterium tuberculosis drug resistance, Abkhazia.

Pardini M, Iona E, Varaine F, Karakozian H, Arzumanian H, Brunori L, Orefici G, Fattorini L; LONG-DRUG Study Group.

Emerg Infect Dis. 2005 Mar;11(3):501-3. No abstract available.

40.

Glycosaminoglycans mediate invasion and survival of Enterococcus faecalis into macrophages.

Baldassarri L, Bertuccini L, Creti R, Filippini P, Ammendolia MG, Koch S, Huebner J, Orefici G.

J Infect Dis. 2005 Apr 15;191(8):1253-62. Epub 2005 Mar 10.

PMID:
15776371
41.

Cetyl-pyridinium chloride is useful for isolation of Mycobacterium tuberculosis from sputa subjected to long-term storage.

Pardini M, Varaine F, Iona E, Arzumanian E, Checchi F, Oggioni MR, Orefici G, Fattorini L.

J Clin Microbiol. 2005 Jan;43(1):442-4.

42.

Induction of Mycobacterium avium proteins upon infection of human macrophages.

Brunori L, Giannoni F, Bini L, Liberatori S, Frota C, Jenner P, Thoresen OF, Orefici G, Fattorini L.

Proteomics. 2004 Oct;4(10):3078-83.

PMID:
15378697
43.
44.

Inhibition of nitric oxide synthase exacerbates group B streptococcus sepsis and arthritis in mice.

Puliti M, von Hunolstein C, Bistoni F, Orefici G, Tissi L.

Infect Immun. 2004 Aug;72(8):4891-4.

45.

Mycobacterium tuberculosis diverts alpha interferon-induced monocyte differentiation from dendritic cells into immunoprivileged macrophage-like host cells.

Mariotti S, Teloni R, Iona E, Fattorini L, Romagnoli G, Gagliardi MC, Orefici G, Nisini R.

Infect Immun. 2004 Aug;72(8):4385-92.

46.

In vitro activity of protegrin-1 and beta-defensin-1, alone and in combination with isoniazid, against Mycobacterium tuberculosis.

Fattorini L, Gennaro R, Zanetti M, Tan D, Brunori L, Giannoni F, Pardini M, Orefici G.

Peptides. 2004 Jul;25(7):1075-7.

PMID:
15245864
47.

Colour Doppler echocardiography in children with group A streptococcal infection related tic disorders.

Cardona F, Romano A, Cundari G, Ventriglia F, Versacci P, Orefici G.

Indian J Med Res. 2004 May;119 Suppl:186-90.

PMID:
15232192
48.

Characterisation of group A streptococcal (GAS) isolates from children with tic disorders.

Creti R, Cardona F, Pataracchia M, Hunolstein CV, Cundari G, Romano A, Orefici G.

Indian J Med Res. 2004 May;119 Suppl:174-8.

PMID:
15232189
49.

Receptor-mediated endocytosis of biofilm-forming Enterococcus faecalis by rat peritoneal macrophages.

Baldassarri L, Bertuccini L, Ammendolia MG, Cocconcelli P, Arciola CR, Montanaro L, Creti R, Orefici G.

Indian J Med Res. 2004 May;119 Suppl:131-5. Erratum in: Indian J Med Res. 2005 Mar;121(3):208. Lucilla, Baldassarri [corrected to Baldassarri, Lucilla]; Lucia, Bertuccini [corrected to Bertuccini, Lucia]; Grazia, Ammendolia Maria [corrected to Ammendolia, Maria Grazia]; Pierluigi, Cocconcelli [corrected to Cocconcelli, Pierluigi]; Renata, Arciola Ca.

PMID:
15232178
50.

Antibody classes & subclasses induced by mucosal immunization of mice with Streptococcus pyogenes M6 protein & oligodeoxynucleotides containing CpG motifs.

Teloni R, von Hunolstein C, Mariotti S, Donati S, Orefici G, Nisini R.

Indian J Med Res. 2004 May;119 Suppl:126-30.

PMID:
15232177

Supplemental Content

Loading ...
Support Center